PMA device
Bausch and Lomb Polymacon Hydrophilic Contact Lenses
Bausch & Lomb, Inc. · Lenses, Soft Contact, Extended Wear (LPM, Class III) · First FDA decision Jun 28, 2002, newest Jun 28, 2002Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
77
Naming "Bausch"
MAUDE reports
0
Brand "Bausch", since 2015
PubMed studies
1,061
Mentioning "Bausch"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Bausch and Lomb Polymacon Hydrophilic Contact Lenses
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 5 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Hydrophilic Contact LensesNational determinationOn the books80.4Updated Jun 11, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Bausch", any status and sponsor, newest update first.
Milton S. Hershey Medical CenterAcademic, hospital or other
NCT07385014 · 80 participants · Start Jul 27, 2023 · Primary completion Sep 22, 2025
Device: Neutral Aspheric Monofocal IOL; Negative Aspheric Monofocal IOL · For: Cataract; Presbyopia
Sites: Hershey, Pennsylvania
Augenklinik Ahaus G + H GmbH & Co. KGAcademic, hospital or other
NCT07051720 · 180 participants (planned) · Start Apr 12, 2022 · Primary completion Oct 2025
Device: Bilateral implantation of CT ASPHINA 409M; Bilateral implantation of TECNIS Eyhance ICB00 and 4 more · For: Cataract and IOL Surgery; IOL Implantation; Presbyopia Correction and 1 more
Sites: Ahaus, Germany
- A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in ChildrenPivotal-lookingRecruiting
Bausch & Lomb IncorporatedNot on our public-company list
NCT06305663 · 418 participants (planned) · Start Mar 29, 2024 · Primary completion Jan 31, 2027
Device: Bausch + Lomb (kalifilcon A) Myopia Control Soft (Hydrophilic); CooperVision MiSight (omafilcon A/60%) Myopia Control one day Soft Contact Lens · For: Myopia
Sites: Beijing, China; Dongcheng, China; Xiamen, China · 11 sites in all
74 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Bausch", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LPM
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Bausch"[tiab]. The summary above synthesizes these.
- Reply to Antinori and Bausch-Jurken.
d'Entremont-Harris M, Ramsey TD, Pelletier É, et al. · J Infect Dis · 2024Letter
- Daniel Bausch-linking tropical medicine to human rights.
Samarasekera U · Lancet Infect Dis · 2023
- Sustained-release corticosteroid options.
Cabrera M, Yeh S, Albini TA · J Ophthalmol · 2014Review
- Bausch & lomb.
Anal Chem · 1983
- Bausch & lomb.
Anal Chem · 1981
- Bausch & lomb.
Anal Chem · 1970
- Bausch & lomb.
Anal Chem · 1972
- Bausch & lomb.
Anal Chem · 1970
- Bausch & lomb.
Anal Chem · 1970
- Bausch & lomb.
Anal Chem · 1983
- Bausch & lomb.
Anal Chem · 1983
- Bausch & lomb.
Anal Chem · 1981
Other devices of this type
Also filed under product code LPM.
- methafilcon A Soft (Hydrophilic) Extended Wear Contact LensesCooperVision, Inc. · PMA 2019
- Biofinity (Confilcon A) Soft Contact LensesCooperVision, Inc. · PMA 2012
- Sofmed® breathables XW NEXTCooperVision, Inc. · PMA 2025
- up&up Monthly Performance +CooperVision, Inc. · PMA 2025
- VISTAKON® (etafilcon A) Brand Contact LensesVistakon, Johnson & Johnson Vision Products, Inc. · PMA 2022
- VISTAKON® (senofilcon A) Brand Contact LensesVistakon, Division of Johnson & Johnson Vision Car · PMA 2022
- Ethos AquaTech Monthly XR, Ethos AquaTech Monthly XR for AstigmatismCooperVision, Inc. · PMA 2022
- Natural Eyes HydraWear XW Extended ParametersCooperVision, Inc. · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.